Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019

NCT04371601 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

COVID-19 Pneumonia

Interventions

DRUG: Oseltamivir
DRUG: hormones
DEVICE: oxygen therapy
PROCEDURE: mesenchymal stem cells

Sponsor

Fuzhou General Hospital